activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Antagonist	2897254	CHEMBL1061190	Concentration-dependent inhibition of ERK5 phosphorylation shift in EGF-stimulated HeLa cells	F	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442		Activity			CHEMBL4948	Homo sapiens	Activity		
Antagonist	2897254	CHEMBL1061190	Concentration-dependent inhibition of ERK5 phosphorylation shift in EGF-stimulated HeLa cells	F	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442		Activity			CHEMBL4948	Homo sapiens	Activity		
Antagonist	2897255	CHEMBL1061190	Concentration-dependent inhibition of ERK5 phosphorylation shift in EGF-stimulated HeLa cells	F	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361		Activity			CHEMBL4948	Homo sapiens	Activity		
Antagonist	2897256	CHEMBL1061190	Concentration-dependent inhibition of ERK5 phosphorylation shift in EGF-stimulated HeLa cells	F	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL573819		Activity			CHEMBL4948	Homo sapiens	Activity		
Antagonist	2897257	CHEMBL1061190	Concentration-dependent inhibition of ERK5 phosphorylation shift in EGF-stimulated HeLa cells	F	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL573579		Activity			CHEMBL4948	Homo sapiens	Activity		
	3213948	CHEMBL1114904	Inhibition of MAP2K5 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	60.0	CHEMBL4948	Homo sapiens	INH	%	60.0
	3293542	CHEMBL1120768	Inhibition of EGF-induced MEK5-mediated ERK1/2 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	COc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1096834	=	Inhibition	%	35.98	CHEMBL4948	Homo sapiens	INH	%	35.98
	3293543	CHEMBL1120768	Inhibition of EGF-induced MEK5-mediated ERK1/2 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	COc1cc(N(Cc2ccccc2)Cc2ccccc2)c2ncn(C(C)C)c2c1	Outside typical range	CHEMBL1097120	=	Inhibition	%	260.57	CHEMBL4948	Homo sapiens	INH	%	260.57
	3293544	CHEMBL1120768	Inhibition of EGF-induced MEK5-mediated ERK1/2 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	CC(C)n1cnc2c(NCc3ccccc3)cc(Cc3ccccc3)cc21	Outside typical range	CHEMBL1097121	=	Inhibition	%	461.55	CHEMBL4948	Homo sapiens	INH	%	461.55
	3293545	CHEMBL1120768	Inhibition of EGF-induced MEK5-mediated ERK1/2 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	CC(C)n1cnc2c(NCc3ccccc3)cc(Cc3ccccc3F)cc21	Outside typical range	CHEMBL1097122	=	Inhibition	%	309.67	CHEMBL4948	Homo sapiens	INH	%	309.67
	3293546	CHEMBL1120768	Inhibition of EGF-induced MEK5-mediated ERK1/2 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	CC(C)n1cnc2c(NCc3ccccc3)cc(Cc3cccc(Cl)c3)cc21	Outside typical range	CHEMBL1099000	=	Inhibition	%	346.25	CHEMBL4948	Homo sapiens	INH	%	346.25
	3293547	CHEMBL1120768	Inhibition of EGF-induced MEK5-mediated ERK1/2 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	CCC(CO)Oc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1	Outside typical range	CHEMBL1099005	=	Inhibition	%	331.95	CHEMBL4948	Homo sapiens	INH	%	331.95
	3293548	CHEMBL1120768	Inhibition of EGF-induced MEK5-mediated ERK1/2 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	c1ccc(CNc2cc(Cc3ccccc3)cc3c2ncn3C2CCCC2)cc1	Outside typical range	CHEMBL1098842	=	Inhibition	%	521.18	CHEMBL4948	Homo sapiens	INH	%	521.18
	3293549	CHEMBL1120768	Inhibition of EGF-induced MEK5-mediated ERK1/2 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	CCC(CO)Oc1cc(NCc2ccccc2)c2ncn(C3CCCC3)c2c1	Outside typical range	CHEMBL1098843	=	Inhibition	%	609.86	CHEMBL4948	Homo sapiens	INH	%	609.86
	3293550	CHEMBL1120768	Inhibition of EGF-induced MEK5-mediated ERK1/2 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	COc1cc(NCc2ccccc2)c2ncn(Cc3ccccc3)c2c1	Outside typical range	CHEMBL1095207	=	Inhibition	%	436.18	CHEMBL4948	Homo sapiens	INH	%	436.18
	3293551	CHEMBL1120769	Inhibition of EGF-induced MEK5-mediated ERK5 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	COc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1096834	=	Inhibition	%	12.35	CHEMBL4948	Homo sapiens	INH	%	12.35
	3293552	CHEMBL1120769	Inhibition of EGF-induced MEK5-mediated ERK5 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	COc1cc(N(Cc2ccccc2)Cc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1097120	=	Inhibition	%	110.05	CHEMBL4948	Homo sapiens	INH	%	110.05
	3293553	CHEMBL1120769	Inhibition of EGF-induced MEK5-mediated ERK5 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	CC(C)n1cnc2c(NCc3ccccc3)cc(Cc3ccccc3)cc21		CHEMBL1097121	=	Inhibition	%	129.49	CHEMBL4948	Homo sapiens	INH	%	129.49
	3293554	CHEMBL1120769	Inhibition of EGF-induced MEK5-mediated ERK5 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	CC(C)n1cnc2c(NCc3ccccc3)cc(Cc3ccccc3F)cc21		CHEMBL1097122	=	Inhibition	%	70.84	CHEMBL4948	Homo sapiens	INH	%	70.84
	3293555	CHEMBL1120769	Inhibition of EGF-induced MEK5-mediated ERK5 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	CC(C)n1cnc2c(NCc3ccccc3)cc(Cc3cccc(Cl)c3)cc21		CHEMBL1099000	=	Inhibition	%	96.27	CHEMBL4948	Homo sapiens	INH	%	96.27
	3293556	CHEMBL1120769	Inhibition of EGF-induced MEK5-mediated ERK5 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	CCC(CO)Oc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1099005	=	Inhibition	%	135.22	CHEMBL4948	Homo sapiens	INH	%	135.22
	3293557	CHEMBL1120769	Inhibition of EGF-induced MEK5-mediated ERK5 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	c1ccc(CNc2cc(Cc3ccccc3)cc3c2ncn3C2CCCC2)cc1		CHEMBL1098842	=	Activity	%	78.0	CHEMBL4948	Homo sapiens	Activity	%	78.0
	3293558	CHEMBL1120769	Inhibition of EGF-induced MEK5-mediated ERK5 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	CCC(CO)Oc1cc(NCc2ccccc2)c2ncn(C3CCCC3)c2c1		CHEMBL1098843	=	Activity	%	131.53	CHEMBL4948	Homo sapiens	Activity	%	131.53
	3293559	CHEMBL1120769	Inhibition of EGF-induced MEK5-mediated ERK5 phosphorylation in human HEK293 cells at 10 uM treated after 30 mins EGF challenge measured after 30 mins by Western blot analysis relative to control	B	COc1cc(NCc2ccccc2)c2ncn(Cc3ccccc3)c2c1		CHEMBL1095207	=	Activity	%	135.59	CHEMBL4948	Homo sapiens	Activity	%	135.59
	3358666	CHEMBL1174908	Inhibition of MEK5 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.4	CHEMBL4948	Homo sapiens	INH	%	0.4
	3359108	CHEMBL1174908	Inhibition of MEK5 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.4	CHEMBL4948	Homo sapiens	INH	%	0.4
Not Active	3446233	CHEMBL1244373	Inhibition of MAP2K5	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441		IC50			CHEMBL4948	Homo sapiens	IC50		
	3557923	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	COc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1096834	=	Activity	%	15.0	CHEMBL4948	Homo sapiens	Activity	%	15.0
	3557924	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277060	=	Activity	%	37.0	CHEMBL4948	Homo sapiens	Activity	%	37.0
	3557925	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277149	=	Activity	%	76.0	CHEMBL4948	Homo sapiens	Activity	%	76.0
	3557926	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CCCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277150	=	Activity	%	95.0	CHEMBL4948	Homo sapiens	Activity	%	95.0
	3557927	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	COCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277151	=	Activity	%	115.0	CHEMBL4948	Homo sapiens	Activity	%	115.0
	3557928	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CC(C)Oc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277238	=	Activity	%	78.0	CHEMBL4948	Homo sapiens	Activity	%	78.0
	3557929	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CCOCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277239	=	Activity	%	25.0	CHEMBL4948	Homo sapiens	Activity	%	25.0
	3557930	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	COCCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277331	=	Activity	%	50.0	CHEMBL4948	Homo sapiens	Activity	%	50.0
	3557931	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CC(C)n1cnc2c(NCc3ccccc3)cc(OCCCN3CCOCC3)cc21		CHEMBL1277061	=	Activity	%	100.0	CHEMBL4948	Homo sapiens	Activity	%	100.0
	3557932	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	COc1cc(N)c2c(c1)N(C(C)C)CN2		CHEMBL1275880	=	Activity	%	58.0	CHEMBL4948	Homo sapiens	Activity	%	58.0
	3557933	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	COCCCOc1cc(N)c2c(c1)N(C(C)C)CN2		CHEMBL1275881	=	Activity	%	32.0	CHEMBL4948	Homo sapiens	Activity	%	32.0
	3557934	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CN1CCN(c2ccc3[nH]c(-c4ccc5[nH]c(-c6ccc(O)cc6)nc5c4)nc3c2)CC1		CHEMBL301735	=	Activity	%	70.0	CHEMBL4948	Homo sapiens	Activity	%	70.0
	3557935	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Activity	%	78.0	CHEMBL4948	Homo sapiens	Activity	%	78.0
	3557936	CHEMBL1286034	Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	73.0	CHEMBL4948	Homo sapiens	Activity	%	73.0
	3557937	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	COc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1096834	=	Inhibition	%	85.0	CHEMBL4948	Homo sapiens	INH	%	85.0
	3557938	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277060	=	Inhibition	%	63.0	CHEMBL4948	Homo sapiens	INH	%	63.0
	3557939	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277149	=	Inhibition	%	24.0	CHEMBL4948	Homo sapiens	INH	%	24.0
	3557940	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CCCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277150	=	Inhibition	%	5.0	CHEMBL4948	Homo sapiens	INH	%	5.0
	3557941	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CC(C)Oc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277238	=	Inhibition	%	22.0	CHEMBL4948	Homo sapiens	INH	%	22.0
	3557942	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CCOCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277239	=	Inhibition	%	75.0	CHEMBL4948	Homo sapiens	INH	%	75.0
	3557943	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	COCCCOc1cc(NCc2ccccc2)c2ncn(C(C)C)c2c1		CHEMBL1277331	=	Inhibition	%	51.0	CHEMBL4948	Homo sapiens	INH	%	51.0
	3557944	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CC(C)n1cnc2c(NCc3ccccc3)cc(OCCCN3CCOCC3)cc21		CHEMBL1277061	=	Inhibition	%	0.0	CHEMBL4948	Homo sapiens	INH	%	0.0
	3557945	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	COc1cc(N)c2c(c1)N(C(C)C)CN2		CHEMBL1275880	=	Inhibition	%	42.0	CHEMBL4948	Homo sapiens	INH	%	42.0
	3557946	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	COCCCOc1cc(N)c2c(c1)N(C(C)C)CN2		CHEMBL1275881	=	Inhibition	%	68.0	CHEMBL4948	Homo sapiens	INH	%	68.0
	3557947	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CN1CCN(c2ccc3[nH]c(-c4ccc5[nH]c(-c6ccc(O)cc6)nc5c4)nc3c2)CC1		CHEMBL301735	=	Inhibition	%	30.0	CHEMBL4948	Homo sapiens	INH	%	30.0
	3557948	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	22.0	CHEMBL4948	Homo sapiens	INH	%	22.0
	3557949	CHEMBL1286035	Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Inhibition	%	27.0	CHEMBL4948	Homo sapiens	INH	%	27.0
	6183717	CHEMBL1772050	Binding affinity to human Mek5 	B	Cc1nc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cs1		CHEMBL1474834	=	Kd	nM	47.0	CHEMBL4948	Homo sapiens	Kd	nM	47.0
	7567126	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	2.8	CHEMBL4948	Homo sapiens	Kd	nM	2.8
	7567585	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7568056	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	63.0	CHEMBL4948	Homo sapiens	Kd	nM	63.0
	7568524	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	58.0	CHEMBL4948	Homo sapiens	Kd	nM	58.0
	7568956	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	75.0	CHEMBL4948	Homo sapiens	Kd	nM	75.0
	7569099	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	1500.0	CHEMBL4948	Homo sapiens	Kd	nM	1500.0
	7569559	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7570031	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7570494	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	1400.0	CHEMBL4948	Homo sapiens	Kd	nM	1400.0
	7570921	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	46.0	CHEMBL4948	Homo sapiens	Kd	nM	46.0
	7571075	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7571532	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7572008	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7573056	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7573513	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	3.3	CHEMBL4948	Homo sapiens	Kd	nM	3.3
	7573989	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	99.0	CHEMBL4948	Homo sapiens	Kd	nM	99.0
	7574016	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7574424	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	200.0	CHEMBL4948	Homo sapiens	Kd	nM	200.0
	7575034	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1.8	CHEMBL4948	Homo sapiens	Kd	nM	1.8
	7575495	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	96.0	CHEMBL4948	Homo sapiens	Kd	nM	96.0
	7575989	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7576397	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7577008	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	1300.0	CHEMBL4948	Homo sapiens	Kd	nM	1300.0
	7577503	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	7.4	CHEMBL4948	Homo sapiens	Kd	nM	7.4
	7577973	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	0.16	CHEMBL4948	Homo sapiens	Kd	nM	0.16
	7578378	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	360.0	CHEMBL4948	Homo sapiens	Kd	nM	360.0
	7579398	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	2.5	CHEMBL4948	Homo sapiens	Kd	nM	2.5
	7579872	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	120.0	CHEMBL4948	Homo sapiens	Kd	nM	120.0
	7580341	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	7.3	CHEMBL4948	Homo sapiens	Kd	nM	7.3
	7580744	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	49.0	CHEMBL4948	Homo sapiens	Kd	nM	49.0
	7580932	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7581317	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7581762	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	180.0	CHEMBL4948	Homo sapiens	Kd	nM	180.0
	7582233	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Kd	nM	1100.0	CHEMBL4948	Homo sapiens	Kd	nM	1100.0
	7582697	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7583097	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	260.0	CHEMBL4948	Homo sapiens	Kd	nM	260.0
	7583278	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7583675	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7584120	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	=	Kd	nM	5100.0	CHEMBL4948	Homo sapiens	Kd	nM	5100.0
	7584591	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7585053	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	41.0	CHEMBL4948	Homo sapiens	Kd	nM	41.0
	7585457	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7585608	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1200.0	CHEMBL4948	Homo sapiens	Kd	nM	1200.0
	7586016	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7586462	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7586933	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1100.0	CHEMBL4948	Homo sapiens	Kd	nM	1100.0
	7587387	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7587569	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7587988	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	3100.0	CHEMBL4948	Homo sapiens	Kd	nM	3100.0
	7588441	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	600.0	CHEMBL4948	Homo sapiens	Kd	nM	600.0
	7588912	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7589534	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	140.0	CHEMBL4948	Homo sapiens	Kd	nM	140.0
	7589958	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	7.0	CHEMBL4948	Homo sapiens	Kd	nM	7.0
	7590425	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7590908	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	1400.0	CHEMBL4948	Homo sapiens	Kd	nM	1400.0
	7591507	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7591929	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	32.0	CHEMBL4948	Homo sapiens	Kd	nM	32.0
	7592432	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	3100.0	CHEMBL4948	Homo sapiens	Kd	nM	3100.0
	7592885	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7593474	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	74.0	CHEMBL4948	Homo sapiens	Kd	nM	74.0
	7593909	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1900.0	CHEMBL4948	Homo sapiens	Kd	nM	1900.0
	7593939	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7594412	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7594864	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	8.2	CHEMBL4948	Homo sapiens	Kd	nM	8.2
	7595442	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7595918	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7596389	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	190.0	CHEMBL4948	Homo sapiens	Kd	nM	190.0
	7596836	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	190.0	CHEMBL4948	Homo sapiens	Kd	nM	190.0
	7597425	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	60.0	CHEMBL4948	Homo sapiens	Kd	nM	60.0
	7597898	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4948	Homo sapiens	Kd	nM	10000.0
	7598368	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	480.0	CHEMBL4948	Homo sapiens	Kd	nM	480.0
	7598810	CHEMBL1908418	Binding constant for MEK5 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2.9	CHEMBL4948	Homo sapiens	Kd	nM	2.9
	7956215	CHEMBL1924834	Inhibition of N-terminus flag-tagged MEK5 expressed in baculovirus infected insect cells using [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	=	IC50	nM	5700.0	CHEMBL4948	Homo sapiens	IC50	nM	5700.0
	8009695	CHEMBL1941380	Inhibition of MEK5 at 1 uM	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCOCC4)c3s2)cc1		CHEMBL1938659	=	Inhibition	%	26.0	CHEMBL4948	Homo sapiens	INH	%	26.0
	8009705	CHEMBL1941380	Inhibition of MEK5 at 1 uM	B	NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12		CHEMBL1938642	>	Inhibition	%	90.0	CHEMBL4948	Homo sapiens	INH	%	90.0
	10838724	CHEMBL2014950	Inhibition of MAP2K5 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	1.0	CHEMBL4948	Homo sapiens	INH	%	1.0
	10878756	CHEMBL2025865	Inhibition of MAP2K5 at 1 uM relative to control	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)n2)cc(OC)c1OC		CHEMBL2023534	<	Inhibition	%	30.0	CHEMBL4948	Homo sapiens	INH	%	30.0
	10949929	CHEMBL2049461	Inhibition of N-terminus FLAG-tagged MEK5 expressed in baculovirus expression system using [gamma-33P]-ATP measured after 30 mins by scintillation counting	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	>	IC50	nM	10000.0	CHEMBL4948	Homo sapiens	IC50	nM	10000.0
	12036431	CHEMBL2150266	Inhibition of N-terminal FLAG-tagged MEK5 expressed in baculovirus after 5 mins by scintillation counter	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL4948	Homo sapiens	IC50	nM	10000.0
	12172351	CHEMBL2210617	Inhibition of MEK5 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4948	Homo sapiens	Activity	%	100.0
	12183866	CHEMBL2211522	Inhibition of MAP2K5	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4948	Homo sapiens	pIC50		5.0
	12728094	CHEMBL2351309	Inhibition of N-terminal FLAG-tagged MEK5 (unknown origin) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-33P]ATP addition measured after 30 mins by scintillation counting analysis	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	=	IC50	nM	870.0	CHEMBL4948	Homo sapiens	IC50	nM	870.0
Active	13826421	CHEMBL3088489	Binding affinity to MEK5 (unknown origin)	B	C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1		CHEMBL3086102		Activity			CHEMBL4948	Homo sapiens	Activity		
	13895027	CHEMBL3111959	Inhibition of MEK5 (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	O=C(Nc1ccc(CO)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109142	=	Activity	%	73.0	CHEMBL4948	Homo sapiens	Activity	%	73.0
	14664236	CHEMBL3271238	Inhibition of MEK5 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	83.0	CHEMBL4948	Homo sapiens	INH	%	83.0
	14664237	CHEMBL3271238	Inhibition of MEK5 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	79.0	CHEMBL4948	Homo sapiens	INH	%	79.0
	14664238	CHEMBL3271238	Inhibition of MEK5 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	80.0	CHEMBL4948	Homo sapiens	INH	%	80.0
	15104855	CHEMBL3386813	Inhibition of MEK5 (unknown origin) assessed as residual enzyme activity at 10 uM	B	O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1		CHEMBL3337845	=	Activity	%	31.0	CHEMBL4948	Homo sapiens	Activity	%	31.0
	15144928	CHEMBL3396437	Competitive binding affinity at MEK5 (unknown origin) at 1 uM relative to control	B	Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1		CHEMBL3393706	=	Activity	%	15.0	CHEMBL4948	Homo sapiens	Activity	%	15.0
	15250387	CHEMBL3430291	Binding affinity to human MEK5 at 10 uM relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	<	Activity	%	10.0	CHEMBL4948	Homo sapiens	Activity	%	10.0
	15250394	CHEMBL3430298	Binding affinity to human MEK5	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	=	Kd	nM	150.0	CHEMBL4948	Homo sapiens	Kd	nM	150.0
	15605129	CHEMBL3578903	Competitive binding affinity to MAP2K5 in human A375 cells after 15 mins in presence of ATP analogue	B	CNc1ncc2cc(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)c(C)nc2n1		CHEMBL3577124	=	IC50	nM	800.0	CHEMBL4948	Homo sapiens	IC50	nM	800.0
	16425968	CHEMBL3749074	Inhibition of MEK5 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CN(C)CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3745919	=	Activity	%	0.45	CHEMBL4948	Homo sapiens	Activity	%	0.45
	16578319	CHEMBL3804373	Inhibition of partial length wild type human MEK5 expressed in mammalian system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	0.9	CHEMBL4948	Homo sapiens	Activity	%	0.9
Inactive	17911094	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911095	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911096	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	2040.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	2040.0
Inactive	17911097	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911098	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911099	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911100	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911101	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911102	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911103	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911104	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911105	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911106	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911107	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911108	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911109	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911110	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911111	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911112	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911113	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911114	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911115	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911116	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911117	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911118	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911119	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911120	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911121	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911122	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911123	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	2452.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	2452.0
Inactive	17911124	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911125	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911126	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911127	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	972.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	972.0
Active	17911128	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	=	Kd	nM	2657.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	2657.0
Inactive	17911129	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911130	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911131	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911132	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911133	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	177.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	177.0
Inactive	17911134	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911135	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911136	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911137	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	6797.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	6797.0
Active	17911138	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	65677.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	65677.0
Active	17911139	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	656.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	656.0
Inactive	17911140	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911141	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911142	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911143	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911144	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	146.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	146.0
Inactive	17911145	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911146	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911147	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	2194.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	2194.0
Active	17911148	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	4938.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	4938.0
Inactive	17911149	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911150	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911151	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17911152	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	=	Kd	nM	3348.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	3348.0
Inactive	17911153	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911154	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911155	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1794.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	1794.0
Inactive	17911156	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911157	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911158	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911159	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911160	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911161	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911162	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911163	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911164	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911165	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	58.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	58.0
Inactive	17911166	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911167	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911168	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911169	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1669.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	1669.0
Inactive	17911170	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911171	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Kd	nM	2085.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	2085.0
Active	17911172	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3906.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	3906.0
Inactive	17911173	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911174	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	=	Kd	nM	6558.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	6558.0
Inactive	17911175	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911176	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911177	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911178	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911179	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911180	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911181	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911182	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911183	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911184	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911185	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911186	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911187	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911188	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	=	Kd	nM	30484.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30484.0
Inactive	17911189	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911190	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	1478.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	1478.0
Inactive	17911191	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911192	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911193	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	47.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	47.0
Inactive	17911194	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911195	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911196	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911197	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	147.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	147.0
Inactive	17911198	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911199	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911200	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911201	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911202	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	2388.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	2388.0
Inactive	17911203	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911204	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911205	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911206	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911207	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911208	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911209	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911210	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911211	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911212	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	=	Kd	nM	1996.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	1996.0
Inactive	17911213	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911214	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911215	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Kd	nM	808.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	808.0
Inactive	17911216	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911217	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	405.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	405.0
Inactive	17911218	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911219	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911220	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911221	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911222	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911223	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911224	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	3525.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	3525.0
Inactive	17911225	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911226	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911227	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	=	Kd	nM	609.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	609.0
Uncertain	17911228	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	=	Kd	nM	5927.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	5927.0
Inactive	17911229	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911230	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911231	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	11392.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	11392.0
Inactive	17911232	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911233	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911234	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911235	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911236	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911237	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911238	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911239	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911240	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911241	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	1929.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	1929.0
Inactive	17911242	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911243	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911244	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	180.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	180.0
Inactive	17911245	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911246	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911247	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911248	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	=	Kd	nM	4914.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	4914.0
Inactive	17911249	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911250	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	=	Kd	nM	734.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	734.0
Inactive	17911251	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911252	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	2952.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	2952.0
Inactive	17911253	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911254	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911255	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911256	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911257	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911258	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911259	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911260	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911261	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911262	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911263	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911264	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	2033.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	2033.0
Inactive	17911265	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911266	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911267	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911268	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911269	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911270	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911271	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911272	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	=	Kd	nM	3576.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	3576.0
Inactive	17911273	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911274	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911275	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911276	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911277	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911278	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911279	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911280	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	535.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	535.0
Inactive	17911281	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911282	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911283	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911284	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911285	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911286	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911287	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911288	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911289	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911290	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911291	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911292	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911293	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911294	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911295	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	1196.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	1196.0
Inactive	17911296	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911297	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	=	Kd	nM	1255.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	1255.0
Inactive	17911298	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911299	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	Kd	nM	9430.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	9430.0
Inactive	17911300	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911301	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911302	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911303	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911304	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911305	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911306	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911307	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1598.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	1598.0
Active	17911308	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	160.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	160.0
Inactive	17911309	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911310	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	2910.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	2910.0
Inactive	17911311	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911312	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911313	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	41.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	41.0
Active	17911314	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1432.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	1432.0
Inactive	17911315	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911316	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911317	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	243.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	243.0
Inactive	17911318	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911319	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911320	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911321	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911322	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911323	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	2294.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	2294.0
Inactive	17911324	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911325	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911326	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Kd	nM	82.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	82.0
Inactive	17911327	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911328	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911329	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911330	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911331	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911332	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911333	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17911334	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
Active	17911335	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	3416.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	3416.0
Inactive	17911336	CHEMBL3991755	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4948	Homo sapiens	Kd apparent	nM	30000.0
	18114257	CHEMBL4025237	Inhibition of wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	98.0	CHEMBL4948	Homo sapiens	Activity	%	98.0
	18153079	CHEMBL4034376	Inhibition of MAP2K5 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	4.5	CHEMBL4948	Homo sapiens	INH	%	4.5
	18182602	CHEMBL4040056	Inhibition of partial length human MEK5 expressed in mammalian expression system by KINOMEscan assay	B	O=C(CN1CCCC2=C1C(=O)N(C1CC1)C2=O)Nc1ccc(-c2cccnc2)nn1		CHEMBL4087906	=	Kd	nM	1300.0	CHEMBL4948	Homo sapiens	Kd	uM	1.3
	18203761	CHEMBL4044048	Inhibition of wild-type human partial length MEK5 (L98 to P448 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	90.0	CHEMBL4948	Homo sapiens	Activity	%	90.0
	18211568	CHEMBL4045735	Inhibition of MAP2K5 conserved Lys2 (DVKPSNMLVNTR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	0.1	CHEMBL4948	Homo sapiens	INH	%	0.1
	18211880	CHEMBL4045976	Inhibition of MAP2K5 conserved Lys2 (DVKPSNMLVNTR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-11.8	CHEMBL4948	Homo sapiens	INH	%	-11.8
	18224095	CHEMBL4048340	Inhibition of partial length wild type human MEK5 expressed in mammalian expression system at 0.5 uM by KINOMEscan method relative to control	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(/C=C/c4c(Cl)cccc4Cl)oc23)[C@H](O)C1		CHEMBL4079206	>	Inhibition	%	98.0	CHEMBL4948	Homo sapiens	INH	%	98.0
	18232356	CHEMBL4050454	Binding affinity to wild-type human MEK5 expressed in mammalian system assessed as control score at 1 uM by KINOMEScan assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(OCc4ccccn4)c(Cl)c3)c3c(N)ncnc32)C1		CHEMBL4068839	=	Activity	%	0.1	CHEMBL4948	Homo sapiens	Activity	%	0.1
	18253229	CHEMBL4054898	Inhibition of human MAP2K5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	5.0	CHEMBL4948	Homo sapiens	Activity	%	5.0
	18253230	CHEMBL4054898	Inhibition of human MAP2K5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	34.0	CHEMBL4948	Homo sapiens	Activity	%	34.0
	18255298	CHEMBL4055572	Binding affinity to partial length human MEK5 expressed in HEK293 cells by active-site-dependent competition assay	B	COc1n[nH]c2ncc(C#Cc3c(F)ccc(NS(=O)(=O)c4cccc(C#N)c4)c3F)cc12		CHEMBL4098896	=	Kd	nM	88.0	CHEMBL4948	Homo sapiens	Kd	nM	88.0
	18255308	CHEMBL4055582	Inhibition of partial length human MEK5 expressed in HEK293 cells assessed as remaining activity at 1 uM after 1 hr by KINOMEscan method	B	COc1n[nH]c2ncc(C#Cc3c(F)ccc(NS(=O)(=O)c4cccc(C#N)c4)c3F)cc12		CHEMBL4098896	=	Activity	%	0.9	CHEMBL4948	Homo sapiens	Activity	%	0.9
	18275034	CHEMBL4118390	Inhibition of MAP2K5 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DVKPSNMLVNTR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	38.1	CHEMBL4948	Homo sapiens	INH	%	38.1
	18275035	CHEMBL4118390	Inhibition of MAP2K5 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DVKPSNMLVNTR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-59.6	CHEMBL4948	Homo sapiens	INH	%	-59.6
	18275036	CHEMBL4118390	Inhibition of MAP2K5 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DVKPSNMLVNTR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	86.8	CHEMBL4948	Homo sapiens	INH	%	86.8
	18275371	CHEMBL4118505	Inhibition of human MEK5 (98 to 448 residues) expressed in mammalian expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	0.2	CHEMBL4948	Homo sapiens	Activity	%	0.2
Active	18275798	CHEMBL4118758	Binding affinity to MAP2K5 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL4948	Homo sapiens	Activity		
Active	18275943	CHEMBL4118903	Binding affinity to MAP2K5 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL4948	Homo sapiens	Activity		
	18276143	CHEMBL4119073	Inhibition of human MEK5 (98 to 448 residues) expressed in mammalian expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	0.1	CHEMBL4948	Homo sapiens	Activity	%	0.1
	18297705	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	O=C(O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL2146885	=	Inhibition	%	20.1	CHEMBL4948	Homo sapiens	INH	%	20.1
	18297706	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	NC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL396548	=	Inhibition	%	59.0	CHEMBL4948	Homo sapiens	INH	%	59.0
	18297707	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CN(C)C(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL4129239	=	Inhibition	%	0.2	CHEMBL4948	Homo sapiens	INH	%	0.2
	18297708	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CCN(CC)C(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL4126075	=	Inhibition	%	0.0	CHEMBL4948	Homo sapiens	INH	%	0.0
	18297709	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CNC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL4128260	=	Inhibition	%	20.4	CHEMBL4948	Homo sapiens	INH	%	20.4
	18297710	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	COC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL4128403	=	Inhibition	%	13.0	CHEMBL4948	Homo sapiens	INH	%	13.0
	18297711	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CCNC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL4127026	=	Inhibition	%	8.5	CHEMBL4948	Homo sapiens	INH	%	8.5
	18297712	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CN(C)CCN(C)C(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL4127424	=	Inhibition	%	9.4	CHEMBL4948	Homo sapiens	INH	%	9.4
	18297713	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CC(C)(C)OC(=O)N1CCN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)CC1		CHEMBL4126037	=	Inhibition	%	8.4	CHEMBL4948	Homo sapiens	INH	%	8.4
	18297714	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CCNCC1		CHEMBL4125962	=	Inhibition	%	0.0	CHEMBL4948	Homo sapiens	INH	%	0.0
	18297715	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	NC(=O)c1ccccc1Nc1ccccc1F		CHEMBL4127342	=	Inhibition	%	39.0	CHEMBL4948	Homo sapiens	INH	%	39.0
	18297716	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CN1CCN(C(=O)c2ccccc2Nc2ccc(I)cc2F)CC1		CHEMBL4127200	=	Inhibition	%	30.9	CHEMBL4948	Homo sapiens	INH	%	30.9
	18297717	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CN1CCN(C(=O)c2ccccc2Nc2ccccc2)CC1		CHEMBL4130057	=	Inhibition	%	71.0	CHEMBL4948	Homo sapiens	INH	%	71.0
	18297718	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	O=C(O)c1ccc(F)c(F)c1Nc1ccccc1F		CHEMBL4126660	=	Inhibition	%	0.0	CHEMBL4948	Homo sapiens	INH	%	0.0
	18297719	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	O=C(O)c1ccc(F)c(F)c1Nc1ccccc1		CHEMBL4130265	=	Inhibition	%	0.0	CHEMBL4948	Homo sapiens	INH	%	0.0
	18297720	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	NC(=O)c1ccc(F)c(F)c1Nc1ccccc1F		CHEMBL4129409	=	Inhibition	%	24.5	CHEMBL4948	Homo sapiens	INH	%	24.5
	18297721	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	NC(=O)c1ccc(F)c(F)c1Nc1ccccc1		CHEMBL4126109	=	Inhibition	%	14.8	CHEMBL4948	Homo sapiens	INH	%	14.8
	18297722	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CN1CCN(C(=O)c2ccc(F)c(F)c2Nc2ccccc2F)CC1		CHEMBL4126226	=	Inhibition	%	56.1	CHEMBL4948	Homo sapiens	INH	%	56.1
	18297723	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CN1CCN(C(=O)c2ccc(F)c(F)c2Nc2ccccc2)CC1		CHEMBL4127601	=	Inhibition	%	82.4	CHEMBL4948	Homo sapiens	INH	%	82.4
	18297724	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CN(c1ccc(I)cc1F)c1c(C(=O)O)ccc(F)c1F		CHEMBL4127455	=	Inhibition	%	18.4	CHEMBL4948	Homo sapiens	INH	%	18.4
	18297725	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CN(c1ccc(I)cc1F)c1c(C(N)=O)ccc(F)c1F		CHEMBL4126070	=	Inhibition	%	0.0	CHEMBL4948	Homo sapiens	INH	%	0.0
	18297726	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	COC(=O)c1ccc(F)c(F)c1N(C)c1ccc(I)cc1F		CHEMBL4128697	=	Inhibition	%	91.6	CHEMBL4948	Homo sapiens	INH	%	91.6
	18297727	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CN1CCN(C(=O)c2ccc(F)c(F)c2N(C)c2ccc(I)cc2F)CC1		CHEMBL4127308	=	Inhibition	%	27.2	CHEMBL4948	Homo sapiens	INH	%	27.2
	18297728	CHEMBL4124008	Activation of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as increase in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	A	CCN(CC)C(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL4126075	=	Activity	%	20.0	CHEMBL4948	Homo sapiens	Activity	%	20.0
	18297729	CHEMBL4124008	Activation of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as increase in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	A	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CCNCC1		CHEMBL4125962	=	Activity	%	20.0	CHEMBL4948	Homo sapiens	Activity	%	20.0
	18297731	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Inhibition	%	95.9	CHEMBL4948	Homo sapiens	INH	%	95.9
	18297732	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Inhibition	%	43.0	CHEMBL4948	Homo sapiens	INH	%	43.0
	18297733	CHEMBL4124005	Inhibition of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as reduction in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	B	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673046	=	Inhibition	%	95.2	CHEMBL4948	Homo sapiens	INH	%	95.2
	18297735	CHEMBL4124008	Activation of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as increase in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	A	O=C(O)c1ccc(F)c(F)c1Nc1ccccc1F		CHEMBL4126660	=	Activity	%	20.0	CHEMBL4948	Homo sapiens	Activity	%	20.0
	18297736	CHEMBL4124008	Activation of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as increase in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	A	O=C(O)c1ccc(F)c(F)c1Nc1ccccc1		CHEMBL4130265	=	Activity	%	20.0	CHEMBL4948	Homo sapiens	Activity	%	20.0
	18297737	CHEMBL4124008	Activation of MEK5 in EGF-stimulated human MDA-MB-231 cells assessed as increase in pERK5 levels preincubated for 30 mins followed by EGF stimulation measured after 15 mins by Western blot analysis relative to control	A	CN(c1ccc(I)cc1F)c1c(C(N)=O)ccc(F)c1F		CHEMBL4126070	=	Activity	%	20.0	CHEMBL4948	Homo sapiens	Activity	%	20.0
	18379251	CHEMBL4145357	Inhibition of wild-type human partial length MAP2K5 (L98 to P448 residues) expressed in mammalian expression system at 10 uM by ATP-site competition binding assay based KinomeScan assay relative to control	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1N		CHEMBL4172550	>	Inhibition	%	90.0	CHEMBL4948	Homo sapiens	INH	%	90.0
	18440303	CHEMBL4157127	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL4948	Homo sapiens	Activity	%	100.0
	18484259	CHEMBL4185906	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	99.0	CHEMBL4948	Homo sapiens	Activity	%	99.0
	18484743	CHEMBL4185906	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	90.0	CHEMBL4948	Homo sapiens	Activity	%	90.0
	18655429	CHEMBL4230806	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4948	Homo sapiens	Activity	%	100.0
	18752002	CHEMBL4264395	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	81.0	CHEMBL4948	Homo sapiens	Activity	%	81.0
	18858059	CHEMBL4307905	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	77.0	CHEMBL4948	Homo sapiens	Activity	%	77.0
	18893644	CHEMBL4315126	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system by Kinomescan method relative to control	B	CC(C)c1ccc(/C=C/c2nc(NCCN(C)C)c3ccccc3n2)cc1		CHEMBL4471700	=	Activity	%	82.0	CHEMBL4948	Homo sapiens	Activity	%	82.0
	18938071	CHEMBL4327762	Inhibition of human MEK5 assessed as residual activity at 1 uM using ERK5 as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	100.06	CHEMBL4948	Homo sapiens	Activity	%	100.06
	18938072	CHEMBL4327762	Inhibition of human MEK5 assessed as residual activity at 1 uM using ERK5 as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.98	CHEMBL4948	Homo sapiens	Activity	%	96.98
	18938607	CHEMBL4328126	Inhibition of human MEK5 assessed as residual activity at 100 uM using ERK5 as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4948	Homo sapiens	Activity	%	65.0
	18938987	CHEMBL4328490	Inhibition of human MEK5 using ERK5 as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	40.4	CHEMBL4948	Homo sapiens	IC50	10'-8M	4.04
	18958970	CHEMBL4333492	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL4948	Homo sapiens	Activity	%	100.0
	19021526	CHEMBL4347748	Inhibition of recombinant human MEK5 at 20 nM using Ulight-ARTKQTARKSTGGKAPRKQLAGCG as substrate measured after 120 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	16.0	CHEMBL4948	Homo sapiens	INH	%	16.0
	19021527	CHEMBL4347749	Inhibition of recombinant human MEK5 at 200 nM using Ulight-ARTKQTARKSTGGKAPRKQLAGCG as substrate measured after 120 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	33.0	CHEMBL4948	Homo sapiens	INH	%	33.0
	19059683	CHEMBL4357984	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	81.0	CHEMBL4948	Homo sapiens	Activity	%	81.0
	19089937	CHEMBL4365541	Inhibition of GST-tagged MEK5 (unknown origin) expressed in baculovirus expression system incubated for 90 mins by HTS assay	B	CN(C)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)C)ccc32)c2ccccc2)c1		CHEMBL2381342	=	IC50	nM	1.5	CHEMBL4948	Homo sapiens	IC50	nM	1.5
	19090248	CHEMBL4365822	Inhibition of wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	0.3	CHEMBL4948	Homo sapiens	Activity	%	0.3
	19092000	CHEMBL4366474	Inhibition of human MEK5 at 100 nM using ERK5 as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-3.16	CHEMBL4948	Homo sapiens	INH	%	-3.16
	19114720	CHEMBL4371453	Binding affinity to MAP2K5 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	539.0	CHEMBL4948	Homo sapiens	Kd(free)	uM	0.539
	19159511	CHEMBL4382615	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	28.0	CHEMBL4948	Homo sapiens	Activity	%	28.0
	19191496	CHEMBL4389334	Inhibition of wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	18.0	CHEMBL4948	Homo sapiens	INH	%	18.0
	19191997	CHEMBL4389811	Inhibition of wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	67.0	CHEMBL4948	Homo sapiens	INH	%	67.0
	19200253	CHEMBL4391437	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	1.6	CHEMBL4948	Homo sapiens	Activity	%	1.6
Active	19218923	CHEMBL4394536	Binding affinity to MAP2K5 in human SUM159 cell lysates by multiplexed inhibitor bead profiling-based LC-MS/MS analysis	B	COc1cc2nccc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OC		CHEMBL4447797		Activity			CHEMBL4948	Homo sapiens	Activity		
	19266496	CHEMBL4405446	Inhibition of wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4948	Homo sapiens	INH	%	50.0
	19292309	CHEMBL4411560	Inhibition of N-terminal GST tagged full length human MAP2K5 (1 to 448 end residues) co-expressing His tagged MAP3K3/ CDC37/HSP90 expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	70.0	CHEMBL4948	Homo sapiens	INH	%	70.0
	19407709	CHEMBL4426908	Binding affinity to human MEK5	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241	=	Kd	nM	38.0	CHEMBL4948	Homo sapiens	Kd	nM	38.0
	19469414	CHEMBL4478333	Inhibition of human MEK5 expressed in mammalian system assessed as remaining enzyme activity at 1 uM relative to untreated control	B	Cc1cc(Nc2ncc3ncc(=O)n(-c4ccc(N)cc4)c3n2)ccc1N1CCN(C)CC1		CHEMBL4550647	<=	Activity	%	1.0	CHEMBL4948	Homo sapiens	Activity	%	1.0
	20602005	CHEMBL4603937	Inhibition of wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as enzyme residual activity at 10 uM by Kinomescan method relative to control	B	c1ccc2sc(-c3cnn4cccnc34)nc2c1		CHEMBL4632827	=	Activity	%	3.9	CHEMBL4948	Homo sapiens	Activity	%	3.9
	20714345	CHEMBL4629869	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	NC(=O)c1cnc(N2CCC[C@H](N)C2)nc1Nc1cccc(C(F)(F)F)c1		CHEMBL1835063	=	Activity	%	7.3	CHEMBL4948	Homo sapiens	Activity	%	7.3
	20714346	CHEMBL4629869	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)(C)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)(C)C)c1		CHEMBL4648967	=	Activity	%	95.0	CHEMBL4948	Homo sapiens	Activity	%	95.0
	20714347	CHEMBL4629869	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)(C#N)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)(C)C#N)c1		CHEMBL4640712	=	Activity	%	9.8	CHEMBL4948	Homo sapiens	Activity	%	9.8
	20714348	CHEMBL4629869	Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)C)n1		CHEMBL4635883	=	Activity	%	0.95	CHEMBL4948	Homo sapiens	Activity	%	0.95
	20714371	CHEMBL4629880	Inhibition of human MEK5 using ERK5 as substrate in presence of [gamma-33P]-ATP by hotspot kinase assay	B	NC(=O)c1cnc(N2CCC[C@H](N)C2)nc1Nc1cccc(C(F)(F)F)c1		CHEMBL1835063	=	IC50	nM	240.0	CHEMBL4948	Homo sapiens	IC50	uM	0.24
	20714372	CHEMBL4629880	Inhibition of human MEK5 using ERK5 as substrate in presence of [gamma-33P]-ATP by hotspot kinase assay	B	CC(C)(C)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)(C)C)c1		CHEMBL4648967	>	IC50	nM	10000.0	CHEMBL4948	Homo sapiens	IC50	uM	10.0
	20714373	CHEMBL4629880	Inhibition of human MEK5 using ERK5 as substrate in presence of [gamma-33P]-ATP by hotspot kinase assay	B	CC(C)(C#N)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)(C)C#N)c1		CHEMBL4640712	=	IC50	nM	7680.0	CHEMBL4948	Homo sapiens	IC50	uM	7.68
	20714374	CHEMBL4629880	Inhibition of human MEK5 using ERK5 as substrate in presence of [gamma-33P]-ATP by hotspot kinase assay	B	CC(C)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)C)n1		CHEMBL4635883	=	IC50	nM	25.0	CHEMBL4948	Homo sapiens	IC50	uM	0.025
	22393861	CHEMBL4667715	Binding affinity to human wild type partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system by Kinomescan method	B	COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL311959	=	Kd	nM	430.0	CHEMBL4948	Homo sapiens	Kd	nM	430.0
	22423473	CHEMBL4674312	Inhibition of human MEK5 using ERK5 as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	97.09	CHEMBL4948	Homo sapiens	Activity	%	97.09
	22423474	CHEMBL4674312	Inhibition of human MEK5 using ERK5 as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	74.71	CHEMBL4948	Homo sapiens	Activity	%	74.71
	22843502	CHEMBL4720497	Inhibition of MEK5 (unknown origin) at 1 uM relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	92.1	CHEMBL4948	Homo sapiens	INH	%	92.1
	22843503	CHEMBL4720497	Inhibition of MEK5 (unknown origin) at 1 uM relative to control	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Inhibition	%	86.8	CHEMBL4948	Homo sapiens	INH	%	86.8
	22843676	CHEMBL4720662	Inhibition of human MEK5 using ERK5 as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	10.1	CHEMBL4948	Homo sapiens	IC50	10^-8M	1.01
	22844025	CHEMBL4721011	Inhibition of human MEK5 assessed as residual activity using ERK5 as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	20.9	CHEMBL4948	Homo sapiens	Activity	%	20.9
	22845454	CHEMBL4721735	Binding affinity to Nluc-tagged MEK5 (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	0.8	CHEMBL4948	Homo sapiens	deltaTm	degrees C	0.8
	22876520	CHEMBL4725971	Inhibition of MEK5 (unknown origin)	B	CN(C)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)C)ccc32)c2ccccc2)c1		CHEMBL2381342	=	IC50	nM	1.5	CHEMBL4948	Homo sapiens	IC50	nM	1.5
	22876521	CHEMBL4725971	Inhibition of MEK5 (unknown origin)	B	CN(C)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(N)=O)ccc32)c2ccccc2)c1		CHEMBL4303171	=	IC50	nM	4.3	CHEMBL4948	Homo sapiens	IC50	nM	4.3
	22926353	CHEMBL4737632	Inhibition of human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by kinome scan method relative to control	B	COc1ncc(-c2ccc3nccc(/C(C)=C/C(=O)N4CCN(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4739883	=	Activity	%	63.0	CHEMBL4948	Homo sapiens	Activity	%	63.0
	23120590	CHEMBL4804415	Inhibition of MAP2K5 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	13400.0	CHEMBL4948	Homo sapiens	IC50	uM	13.4
	23120591	CHEMBL4804415	Inhibition of MAP2K5 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	58000.0	CHEMBL4948	Homo sapiens	IC50	uM	58.0
	23120592	CHEMBL4804415	Inhibition of MAP2K5 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	10900.0	CHEMBL4948	Homo sapiens	IC50	uM	10.9
	23120593	CHEMBL4804415	Inhibition of MAP2K5 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-4000.0	CHEMBL4948	Homo sapiens	IC50	uM	-4.0
	23120594	CHEMBL4804415	Inhibition of MAP2K5 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-15000.0	CHEMBL4948	Homo sapiens	IC50	uM	-15.0
	23120595	CHEMBL4804415	Inhibition of MAP2K5 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	75200.0	CHEMBL4948	Homo sapiens	IC50	uM	75.2
	23121629	CHEMBL4804597	Inhibition of MAP2K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL4948	Homo sapiens	INH	%	0.0
	23121630	CHEMBL4804597	Inhibition of MAP2K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	50.0	CHEMBL4948	Homo sapiens	INH	%	50.0
	23121631	CHEMBL4804597	Inhibition of MAP2K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4948	Homo sapiens	INH	%	0.0
	23121632	CHEMBL4804597	Inhibition of MAP2K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL4948	Homo sapiens	INH	%	0.0
	23121633	CHEMBL4804597	Inhibition of MAP2K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL4948	Homo sapiens	INH	%	0.0
	23121634	CHEMBL4804597	Inhibition of MAP2K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	75.0	CHEMBL4948	Homo sapiens	INH	%	75.0
	23122669	CHEMBL4805020	Inhibition of human MEK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	63.0	CHEMBL4948	Homo sapiens	Activity	%	63.0
	23123364	CHEMBL4805608	Inhibition of human MEK5 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	60.0	CHEMBL4948	Homo sapiens	Activity	%	60.0
	23123823	CHEMBL4806067	Inhibition of DNA-tagged human MEK5 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	97.0	CHEMBL4948	Homo sapiens	Activity	%	97.0
	23124818	CHEMBL4806625	Inhibition of human MEK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	86.0	CHEMBL4948	Homo sapiens	Activity	%	86.0
	23124819	CHEMBL4806625	Inhibition of human MEK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	65.0	CHEMBL4948	Homo sapiens	Activity	%	65.0
	23128293	CHEMBL4807906	Inhibition of MEK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4948	Homo sapiens	Activity	%	75.0
	23128294	CHEMBL4807906	Inhibition of MEK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4948	Homo sapiens	Activity	%	75.0
	23128295	CHEMBL4807906	Inhibition of MEK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4948	Homo sapiens	Activity	%	75.0
	23213428	CHEMBL4822962	Inhibition of human recombinant MAP2K5 by Lanthascreen assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	1.0	CHEMBL4948	Homo sapiens	INH	%	1.0
	23290890	CHEMBL4839440	Inhibition of human recombinant MAP2K5 assessed as residual percent of control by Kinomescan method relative to control	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	Activity	%	15.0	CHEMBL4948	Homo sapiens	Activity	%	15.0
Not Determined	23290891	CHEMBL4839440	Inhibition of human recombinant MAP2K5 assessed as residual percent of control by Kinomescan method relative to control	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188		Activity			CHEMBL4948	Homo sapiens	Activity		
	23294393	CHEMBL4840159	Inhibition of human wild type partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system at 1 uM measured by Kinomescan assay	B	NS(=O)(=O)c1ccc(-c2n[nH]c3cc(F)ccc23)cc1		CHEMBL4879048	=	Inhibition	%	22.0	CHEMBL4948	Homo sapiens	INH	%	22.0
	23294394	CHEMBL4840159	Inhibition of human wild type partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system at 1 uM measured by Kinomescan assay	B	NC(=O)c1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4866649	=	Inhibition	%	87.0	CHEMBL4948	Homo sapiens	INH	%	87.0
	23294403	CHEMBL4840164	Inhibition of human wild type partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system at 10 uM measured by Kinomescan assay	B	NS(=O)(=O)c1ccc(-c2n[nH]c3cc(F)ccc23)cc1		CHEMBL4879048	=	Inhibition	%	76.0	CHEMBL4948	Homo sapiens	INH	%	76.0
	23294404	CHEMBL4840164	Inhibition of human wild type partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system at 10 uM measured by Kinomescan assay	B	NC(=O)c1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4866649	=	Inhibition	%	99.0	CHEMBL4948	Homo sapiens	INH	%	99.0
Not Active	23317504	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	98.0	CHEMBL4948	Homo sapiens	% Control	%	98.0
Not Active	23317972	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	86.0	CHEMBL4948	Homo sapiens	% Control	%	86.0
Not Active	23318639	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	83.0	CHEMBL4948	Homo sapiens	% Control	%	83.0
Not Active	23319122	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	88.0	CHEMBL4948	Homo sapiens	% Control	%	88.0
Not Active	23319759	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23320234	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23320912	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	83.0	CHEMBL4948	Homo sapiens	% Control	%	83.0
Not Active	23321380	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	72.0	CHEMBL4948	Homo sapiens	% Control	%	72.0
Not Active	23322010	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	63.0	CHEMBL4948	Homo sapiens	% Control	%	63.0
Not Active	23322478	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23323167	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	67.0	CHEMBL4948	Homo sapiens	% Control	%	67.0
Not Active	23323635	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	76.0	CHEMBL4948	Homo sapiens	% Control	%	76.0
Slightly Active	23324489	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	49.9	CHEMBL4948	Homo sapiens	% Control	%	49.9
Not Active	23325124	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23325592	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	73.0	CHEMBL4948	Homo sapiens	% Control	%	73.0
Not Active	23326239	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	88.0	CHEMBL4948	Homo sapiens	% Control	%	88.0
Not Active	23326707	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	94.0	CHEMBL4948	Homo sapiens	% Control	%	94.0
Not Active	23327407	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	69.0	CHEMBL4948	Homo sapiens	% Control	%	69.0
Not Active	23327875	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	90.0	CHEMBL4948	Homo sapiens	% Control	%	90.0
Not Active	23328462	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	88.0	CHEMBL4948	Homo sapiens	% Control	%	88.0
Not Active	23328930	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	78.0	CHEMBL4948	Homo sapiens	% Control	%	78.0
Not Active	23329876	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	86.0	CHEMBL4948	Homo sapiens	% Control	%	86.0
Not Active	23330344	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	83.0	CHEMBL4948	Homo sapiens	% Control	%	83.0
Not Active	23331100	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23331568	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	78.0	CHEMBL4948	Homo sapiens	% Control	%	78.0
Not Active	23332155	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	91.8	CHEMBL4948	Homo sapiens	% Control	%	91.8
Slightly Active	23332621	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	35.9	CHEMBL4948	Homo sapiens	% Control	%	35.9
Not Active	23333339	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23333978	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	91.0	CHEMBL4948	Homo sapiens	% Control	%	91.0
Not Active	23334446	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	87.0	CHEMBL4948	Homo sapiens	% Control	%	87.0
Not Active	23335425	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	82.0	CHEMBL4948	Homo sapiens	% Control	%	82.0
Not Active	23335893	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23336520	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23336988	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23338069	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	62.0	CHEMBL4948	Homo sapiens	% Control	%	62.0
Not Active	23338537	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	72.0	CHEMBL4948	Homo sapiens	% Control	%	72.0
Not Active	23339149	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23339617	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	81.0	CHEMBL4948	Homo sapiens	% Control	%	81.0
Not Active	23340254	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	80.0	CHEMBL4948	Homo sapiens	% Control	%	80.0
Not Active	23340722	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	92.0	CHEMBL4948	Homo sapiens	% Control	%	92.0
Not Active	23341379	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	86.0	CHEMBL4948	Homo sapiens	% Control	%	86.0
Not Active	23341847	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	92.0	CHEMBL4948	Homo sapiens	% Control	%	92.0
Active	23342463	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	16.0	CHEMBL4948	Homo sapiens	% Control	%	16.0
Not Active	23342931	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	81.0	CHEMBL4948	Homo sapiens	% Control	%	81.0
Not Active	23343561	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	82.0	CHEMBL4948	Homo sapiens	% Control	%	82.0
Not Active	23344029	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	63.0	CHEMBL4948	Homo sapiens	% Control	%	63.0
Not Active	23344667	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	84.0	CHEMBL4948	Homo sapiens	% Control	%	84.0
Not Active	23345240	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	71.0	CHEMBL4948	Homo sapiens	% Control	%	71.0
Not Active	23345708	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	89.0	CHEMBL4948	Homo sapiens	% Control	%	89.0
Slightly Active	23346285	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	25.2	CHEMBL4948	Homo sapiens	% Control	%	25.2
Not Active	23346753	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	85.2	CHEMBL4948	Homo sapiens	% Control	%	85.2
Not Active	23347355	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	89.1	CHEMBL4948	Homo sapiens	% Control	%	89.1
Active	23347845	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	17.6	CHEMBL4948	Homo sapiens	% Control	%	17.6
Not Active	23348424	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	94.0	CHEMBL4948	Homo sapiens	% Control	%	94.0
Not Active	23348892	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	80.0	CHEMBL4948	Homo sapiens	% Control	%	80.0
Not Active	23349479	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	52.0	CHEMBL4948	Homo sapiens	% Control	%	52.0
Not Active	23350097	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	58.0	CHEMBL4948	Homo sapiens	% Control	%	58.0
Not Active	23350565	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	74.0	CHEMBL4948	Homo sapiens	% Control	%	74.0
Not Active	23351170	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23351638	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23352662	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	90.0	CHEMBL4948	Homo sapiens	% Control	%	90.0
Not Active	23353130	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	93.0	CHEMBL4948	Homo sapiens	% Control	%	93.0
Not Active	23354012	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	96.0	CHEMBL4948	Homo sapiens	% Control	%	96.0
Not Active	23354480	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23355212	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23355680	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	98.0	CHEMBL4948	Homo sapiens	% Control	%	98.0
Not Active	23356316	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23356784	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	96.0	CHEMBL4948	Homo sapiens	% Control	%	96.0
Not Active	23357393	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	92.0	CHEMBL4948	Homo sapiens	% Control	%	92.0
Not Active	23358040	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23358508	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	88.0	CHEMBL4948	Homo sapiens	% Control	%	88.0
Not Active	23359094	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23359692	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23360160	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	88.0	CHEMBL4948	Homo sapiens	% Control	%	88.0
Not Active	23360745	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	83.0	CHEMBL4948	Homo sapiens	% Control	%	83.0
Not Active	23361213	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	84.0	CHEMBL4948	Homo sapiens	% Control	%	84.0
Not Active	23361786	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	68.0	CHEMBL4948	Homo sapiens	% Control	%	68.0
Not Active	23362322	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23362790	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	85.0	CHEMBL4948	Homo sapiens	% Control	%	85.0
Not Active	23364432	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	66.0	CHEMBL4948	Homo sapiens	% Control	%	66.0
Not Active	23364900	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	75.0	CHEMBL4948	Homo sapiens	% Control	%	75.0
Not Active	23365639	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23366182	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23366772	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23367240	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	73.0	CHEMBL4948	Homo sapiens	% Control	%	73.0
Not Active	23368118	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	83.0	CHEMBL4948	Homo sapiens	% Control	%	83.0
Not Active	23368586	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	81.0	CHEMBL4948	Homo sapiens	% Control	%	81.0
Not Active	23368914	CHEMBL4884201	NanoBRET with MAP2K5	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1	Non standard unit for type	CHEMBL4537673	>	IC50	µM	20.0	CHEMBL4948	Homo sapiens	IC50	µM	20.0
Active	23369185	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	8.5	CHEMBL4948	Homo sapiens	% Control	%	8.5
Active	23369653	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	1.8	CHEMBL4948	Homo sapiens	% Control	%	1.8
Not Active	23370621	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23371089	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	79.0	CHEMBL4948	Homo sapiens	% Control	%	79.0
Not Active	23371898	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	97.0	CHEMBL4948	Homo sapiens	% Control	%	97.0
Not Active	23372366	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23375793	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23376261	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23376838	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	79.0	CHEMBL4948	Homo sapiens	% Control	%	79.0
Not Active	23377306	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	87.0	CHEMBL4948	Homo sapiens	% Control	%	87.0
Not Active	23378166	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	83.0	CHEMBL4948	Homo sapiens	% Control	%	83.0
Not Active	23378634	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	89.0	CHEMBL4948	Homo sapiens	% Control	%	89.0
Not Active	23379801	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	62.0	CHEMBL4948	Homo sapiens	% Control	%	62.0
Not Active	23380269	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23380963	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	93.0	CHEMBL4948	Homo sapiens	% Control	%	93.0
Not Active	23381611	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23382079	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4948	Homo sapiens	% Control	%	100.0
Not Active	23382703	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	89.0	CHEMBL4948	Homo sapiens	% Control	%	89.0
Slightly Active	23383171	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	48.0	CHEMBL4948	Homo sapiens	% Control	%	48.0
Not Active	23383628	CHEMBL4887284	MAP2K5 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	107.0	CHEMBL4948	Homo sapiens	% Ctrl	%	107.0
Not Active	23385086	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	60.0	CHEMBL4948	Homo sapiens	% Control	%	60.0
Not Active	23385553	CHEMBL4879810	KinomeScan assay: inhibition of MEK5	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	91.0	CHEMBL4948	Homo sapiens	% Control	%	91.0
